The salivary microbiome as an indicator of carcinogenesis in patients with oropharyngeal squamous cell carcinoma: A pilot studyOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This pilot study examined the salivary microbiome as a possible indicator of carcinogenesis in oral and oropharyngeal squamous cell carcinoma. Researchers compared saliva samples from cancer patients against healthy controls using high-throughput sequencing of the 16S rRNA gene on the MiSeq platform. The goal was an initial, comparative look at whether microbial community composition differs between diseased and healthy states.
Who was studied?
The study included 11 patients with oral and oropharyngeal squamous cell carcinoma (1 female, 10 male, mean age 61.6 years, SD 8.2) and 11 healthy controls (1 female, 10 male, mean age 46.7 years, SD 15.1). This was explicitly framed as a pilot study, meaning the sample size was small and intended to generate preliminary findings rather than definitive conclusions. Saliva was the biological sample analyzed for both groups.
What were the most important findings?
Sequence data revealed microbial changes in saliva that may mirror disease progression in oral and oropharyngeal squamous cell carcinoma. These microbial shifts appeared to reflect clinical preconditions including patient age, alcohol consumption, tumour size, lymph node status, smoking habit, and tumour HPV positivity. The abstract does not report specific taxa, effect sizes, or statistical values, only that detectable compositional differences were observed.
What are the greatest implications of this study?
Mapping microbial changes in the saliva of patients with these cancers could improve understanding of the disease's underlying pathobiology. Such mapping may also support development of novel diagnostic tools and treatment strategies tailored to oral and oropharyngeal squamous cell carcinoma. Because this was a small pilot study, these implications point toward directions for larger, confirmatory research rather than immediate clinical application.